Skip to search.
 TSX Down 2.72% TSX Ventures Down 2.06%

Incyte Corporation (INCY)

-NasdaqGS
115.12 Down 1.07(0.92%) Sep 1, 3:59PM EDT
Add to Portfolio
Prev Close:116.19
Open:114.85
Bid:101.00 x 100
Ask:128.00 x 100
1y Target Est:125.00
Beta:-0.061918
Earnings Date:Oct 28 - Nov 2 (Est.)
Day's Range:114.00 - 118.99
52wk Range:43.86 - 121.93
Volume:1,717,513
Avg Vol (3m):1,126,970
Market Cap:20.78B
P/E (ttm):1,495.06
EPS (ttm):0.08
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
INCYDown 0.92%20.78B
CELGDown 2.22%91.28B
AMGNDown 2.85%111.81B

Key Statistics

Forward P/E (1 yr):164.46
P/S (ttm):32.54
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.13
Quarterly EPS Est (Sep-15) :-0.06
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-12.53

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics primarily for oncology. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback